Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward S Kim

Showing results (31-40 of 188) with videos related to

Pageof 19
Sort By:
Oncology (Williston Park, N.Y.)|December 9, 2010
Bronchioloalveolar carcinoma: a translational perspectivePierre Saintigny, Ignacio I Wistuba, Edward S Kim
Journal of Thoracic Disease|November 13, 2018
Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189Sheenu Sheela, Edward S Kim, Kathryn F Mileham
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 23, 2010
The multidisciplinary approach to thymoma: combining molecular and clinical approachesNicole G Chau, Edward S Kim, Ignacio Wistuba
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Nonsmall-cell lung cancer: chemoprevention studiesDaniel D Karp, Anne S Tsao, Edward S Kim
Nature Clinical Practice. Oncology|February 5, 2009
Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neckWilliam N William, Edward S Kim, Roy S Herbst
Annual Review of Medicine|January 31, 2002
Chemoprevention of aerodigestive tract cancersEdward S Kim, Waun Ki Hong, Fadlo Raja Khuri
Oncology (Williston Park, N.Y.)|April 17, 2019
Targeted Therapy for Mutation-Driven Metastatic Non-Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsKathryn F Mileham, Mufti N Ahmad, Edward S Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Precision Oncology: Who, How, What, When, and When Not?Lee Schwartzberg, Edward S Kim, David Liu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Cotargeting cyclin D1 starts a new chapter in lung cancer prevention and therapyEdward S Kim, J Jack Lee, Ignacio I Wistuba
Expert Opinion on Investigational Drugs|June 7, 2012
Vandetanib for the treatment of lung cancerCaleb T Chu, Yvonne H Sada, Edward S Kim
Pageof 19

Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Oncology (Williston Park, N.Y.)|December 9, 2010
Bronchioloalveolar carcinoma: a translational perspectivePierre Saintigny, Ignacio I Wistuba, Edward S Kim
Journal of Thoracic Disease|November 13, 2018
Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189Sheenu Sheela, Edward S Kim, Kathryn F Mileham
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 23, 2010
The multidisciplinary approach to thymoma: combining molecular and clinical approachesNicole G Chau, Edward S Kim, Ignacio Wistuba
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Nonsmall-cell lung cancer: chemoprevention studiesDaniel D Karp, Anne S Tsao, Edward S Kim
Nature Clinical Practice. Oncology|February 5, 2009
Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neckWilliam N William, Edward S Kim, Roy S Herbst
Annual Review of Medicine|January 31, 2002
Chemoprevention of aerodigestive tract cancersEdward S Kim, Waun Ki Hong, Fadlo Raja Khuri
Oncology (Williston Park, N.Y.)|April 17, 2019
Targeted Therapy for Mutation-Driven Metastatic Non-Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsKathryn F Mileham, Mufti N Ahmad, Edward S Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Precision Oncology: Who, How, What, When, and When Not?Lee Schwartzberg, Edward S Kim, David Liu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Cotargeting cyclin D1 starts a new chapter in lung cancer prevention and therapyEdward S Kim, J Jack Lee, Ignacio I Wistuba
Expert Opinion on Investigational Drugs|June 7, 2012
Vandetanib for the treatment of lung cancerCaleb T Chu, Yvonne H Sada, Edward S Kim
Pageof 19